Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Filings indexed 266 across all filing types
Latest filing 2020-09-02 Report Publication Anno…
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 98% confidence The document is a press release dated September 2, 2020, announcing that IMPLANET will publish its H1 2020 financial results on September 15, 2020, and will hold a conference call afterward. It explicitly lists 'Résultats du 1er semestre 2020' (H1 2020 Results) as a future event. Since the document is an announcement *about* the upcoming release of financial results and includes details for an associated conference call, it functions as a notification of future reporting. This fits the definition of a Report Publication Announcement (RPA), as it announces the publication of a report (the H1 2020 results) rather than being the comprehensive report itself (which would be an IR or ER/MDA). The document length is short (3089 chars), supporting the RPA classification over a full report.
2020-09-02 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated July 21, 2020, announcing a major business development: the start of commercialization for the MADISON knee implant in the United States through a partnership with KICo. It details operational milestones (first surgeries planned for August) and market potential. It is not a formal regulatory filing like a 10-K, nor is it a transcript (CT) or a formal dividend/share change notice. It is an announcement regarding business operations and strategic progress, which often falls under general regulatory announcements or investor relations updates. Since it is a specific business update that doesn't fit the strict definitions of ER (Earnings Release), CAP (Financing), or DIV (Dividend), and it is not a short announcement pointing to a larger report (RPA), the most appropriate general category for significant, non-financial-result-specific corporate news is Regulatory Filings (RNS) as a catch-all for press releases, or potentially a very broad interpretation of Investor Presentation (IP) if it were more strategic, but RNS is safer for general news releases. Given the context of a press release announcing a commercial launch and partnership execution, RNS (Regulatory Filings/General Announcement) is the best fit among the provided options, as it is a standard corporate communication.
2020-07-21 French
Inside Information / Other news releases
Regulatory Filings Classification · 90% confidence The document is a press release dated July 21, 2020, announcing the start of marketing for the MADISON knee range in the United States through a distribution contract with KICo. It details a business development milestone, partnership terms, and future surgical expectations. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a specific business update concerning operations and market entry. Since it is a general announcement about business progress that doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Director's Dealing (DIRS), it falls best under the general Regulatory Filings/Announcements category (RNS) as a miscellaneous corporate update, although it strongly resembles an Investor Presentation (IP) in style, it lacks the typical strategic depth of a formal IP. Given the options, RNS serves as the most appropriate catch-all for significant, non-standard operational news releases.
2020-07-21 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 94% confidence The document announces that Implanet's JAZZ Cap® technology has been patented in Japan, following previous protection in the US and Europe. This announcement focuses on intellectual property expansion and market strategy, which is a general corporate update. It is not a formal financial report (like 10-K or IR), a dividend notice, or an earnings release. Since the core topic is the expansion of intellectual property rights and market access, it fits best under a general regulatory or corporate announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for significant, non-financial, non-management-change corporate news that doesn't fit a specific category like M&A or Director's Dealing. However, the content is highly specific to IP protection, which sometimes falls under 'Legal Proceedings Report' (LTR) if it were about litigation, but here it is about successful patent acquisition. Since there is no specific 'Intellectual Property Update' code, and it is a formal announcement of a corporate milestone, RNS is the best fit as a general regulatory announcement.
2020-07-16 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated July 16, 2020, announcing that the company IMPLANET has secured a patent for its JAZZ Cap® technology in Japan. It discusses intellectual property, market potential, and upcoming financial events (H1 2020 results and Q3 2020 revenue). This type of announcement, focusing on a specific corporate development (patent grant) and providing general company updates, does not fit neatly into the defined financial report categories (10-K, IR, ER, etc.). It is a general corporate announcement. Since it is not a specific regulatory filing like DIRS, DIV, or CAP, and it is not an announcement about the publication of a major report (RPA), the most appropriate fallback category is Regulatory Filings (RNS) for miscellaneous corporate news releases that don't fit elsewhere.
2020-07-16 English
Inside Information / News release on accounts, results
Earnings Release Classification · 96% confidence The document is titled "Implanet announces H1 2020 revenue" and provides detailed financial figures (revenue tables for Q1, Q2, and H1 2020 vs 2019) along with management commentary on the impact of Covid-19. This content structure—presenting key financial metrics for a specific interim period (H1 2020) immediately after the period ends—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it covers the first half (H1), it is a comprehensive interim report, but the format is very brief, focusing only on revenue highlights and management commentary, which aligns closely with the definition of an Earnings Release (ER) which provides initial announcements of periodical financial results (key highlights only). The document explicitly states that the full H1 2020 results will be released later on September 15, 2020. Therefore, this document serves as the preliminary revenue announcement for the interim period, fitting the 'Earnings Release' (ER) category best, as it precedes the full 'Interim Report' (IR). H1 2020
2020-07-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.